PMS29 Abatacept or Infliximab for Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate- A Trial-Based and Real-Life Cost-Consequence Analysis
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.415
https://www.valueinhealthjournal.com/article/S1098-3015(11)01977-2/fulltext
Title :
PMS29 Abatacept or Infliximab for Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate- A Trial-Based and Real-Life Cost-Consequence Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01977-2&doi=10.1016/j.jval.2011.08.415
First page :
A307
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
390